EDC/Data Management White Papers & Case Studies
-
Lotus Clinical Research Speeds Study Startup By 67% With Veeva Clinical Suite
2/22/2022
“The EDC is no longer the bottleneck in study startup. We are reducing overall study start times from three months to four-to-five weeks using Veeva’s Vault Clinical Suite,” says Eric Guitard, Vice President of Systems Integration, Lotus Clinical Research.
-
Synergy Chooses ClinCapture
4/7/2016
In 2007 Synergy opened a Clinical Data Management Department with local, low-budget projects and decided to implement an open source EDC solution as a clinical data collection tool. This tool required installation and validation every time a new project was started. When the number of projects started to multiply, management quickly realized they had two options: expand their IT resources to support data management applications or outsource. They chose the second option so they had to find a cost-effective, pay-as-you-go, cloudbased EDC solution which would allow them to move their current EDC projects without interruption.
-
Electronic Informed Consent: Considerations For Implementation In Clinical Trials
2/23/2015
In an era where data acquisition (eg. ePRO), capture (EDC) and storage (eTMF) are done electronically, it is the logical consequence to do the same for the informed consent process as all the advantages of the electronic modality equally apply to this process.
-
Financial Management With Clinical Conductor Site CTMS At Coastal Carolina Research Center
8/7/2013
The Coastal Carolina Research Center began using Clinical Conductor Site CTMS in 2008.
-
Improve Accuracy And Efficiency In Data Collection For Mental-Health Evaluations And Assessments
5/29/2013
MedAvante is a global provider of centralized, expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries.
-
Beyond EDC: Resolving Data-Entry Challenges Faced By Electronic Data Capture Systems In Clinical Trials
5/8/2013
Electronic Data Capture (EDC) systems have swept the Clinical Trials industry in recent years, promising to transform the drug development process.
-
Military Drug Trials Group Eliminates Errors And Inefficiencies Using Electronic Data Capture And Tablet PCs
5/8/2013
Infectious Disease Clinical Research Program (IDCRP) is a worldwide network of Department of Defense (DoD) clinical and research centers that have collaborated to investigate infectious disease challenges facing the military.
-
Switching EDC Platforms To Rescue In-Flight Clinical Trials
5/7/2013
The decision to switch an EDC platform for in-flight trials is not easy and is fraught with risks. A majority of companies continue to plough forward with higher costs and operational pains due to a failing EDC platform. Read this white paper and learn how Acceliant's low-risk EDC migration can deliver legacy EDC retirement, lower operating costs, and peace of mind for all teams working towards the success of a clinical trial. By Ven Thangaraj, CTO, Acceliant
-
New Molecular Entities (NMEs) - The Path Of Resistance
5/3/2013
On a global scale, the number of new molecular entities (NMEs) in development—and, more importantly, the number being approved by regulatory authorities— has dropped significantly in recent years.
-
Moving Towards An Electronic Environment In Clinical Trials
5/3/2013
With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.